KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Assets (2016 - 2025)

Astrana Health (ASTH) has disclosed Assets for 15 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • Quarterly Assets rose 63.75% to $2.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 billion through Dec 2025, up 63.75% year-over-year, with the annual reading at $2.2 billion for FY2025, 63.75% up from the prior year.
  • Assets hit $2.2 billion in Q4 2025 for Astrana Health, down from $2.2 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $2.2 billion in Q3 2025 to a low of $843.1 million in Q1 2021.
  • Historically, Assets has averaged $1.2 billion across 5 years, with a median of $1.0 billion in 2023.
  • Biggest five-year swings in Assets: dropped 3.4% in 2023 and later surged 74.05% in 2025.
  • Year by year, Assets stood at $867.4 million in 2021, then grew by 11.4% to $966.2 million in 2022, then decreased by 3.4% to $933.4 million in 2023, then skyrocketed by 45.16% to $1.4 billion in 2024, then surged by 63.75% to $2.2 billion in 2025.
  • Business Quant data shows Assets for ASTH at $2.2 billion in Q4 2025, $2.2 billion in Q3 2025, and $1.4 billion in Q2 2025.